CXCR6 and neoplasm: Conversely, the low EFFscore subgroup exhibits enhanced CXCL16-CXCR6 signaling, which may facilitate CD8+ T cell infiltration and enhance tumor-effector function, thereby supporting antitumor immunity (65–67).